IceCure Medical Ltd. Announces $10 Million Rights Offering to Fund Cryoablation Technology Expansion

Reuters
Yesterday
<a href="https://laohu8.com/S/ICCM">IceCure Medical Ltd.</a> Announces $10 Million Rights Offering to Fund Cryoablation Technology Expansion

IceCure Medical Ltd. has announced a rights offering aimed at raising up to $10 million. The offering will provide holders of the company's ordinary shares as of July 9, 2025, with one subscription right per share. Each right allows the holder to subscribe for 0.1703 of a unit, consisting of an ordinary share and a warrant at $1.00 per unit, or alternatively, a unit with a pre-funded warrant at $0.9999 per unit. The rights must be exercised by July 28, 2025. The company's largest shareholder, Epoch Partner Investments Limited, has committed to participate fully, including any over-subscription, up to $5 million. Proceeds from the offering will be used to repay a $2 million bridge loan from Epoch and for general corporate purposes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IceCure Medical Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: IO18147) on June 25, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10